BTG has announced that following positive results of its 15-year experience between 2003 and 2017 with TheraSphere, Northwestern University, Illinois, USA, has adopted Y-90 transarterial radioembolization (TARE; also known as radioembolization, or selective internal radiation therapy [SIRT]) with TheraSphere as the primary transarterial locoregional therapy for patients with hepatocellular carcinoma (HCC) limited to the liver.
A prospective, randomised single-centre study that set out to compare the safety and efficacy of vascular plugs and fibred platinum coils for embolization in pelvic congestion syndrome has shown that while both devices resulted in successful embolization, plugs were associated with decreased fluoroscopy time and radiation dose
Guerbet has announced that it has entered into an agreement under which it will acquire Israeli company Accurate Medical, which specialises in the development of microcatheters used in interventional radiology.
Viz.ai has announced the CE mark of its direct-to-intervention system, ContaCT, a novel approach to stroke care that automatically analyses brain CTs and notifies a specialist that a suspected large vessel occlusion has been identified.
The upcoming annual meeting of the European Society of Radiology (ESR; 28 February – March 4, 2018, in Vienna, Austria) has adopted the motto ‘Diverse and United’ and will feature a brand new programme format titled “Interventional Radiology at the Cube”.
A new study has found that a test that identifies circulating tumour cells (CTCs) present in the bloodstream can detect colorectal cancer at an early stage, with accuracy ranging from 84 to 88%. Collection of CTCs from the blood is one form of “liquid biopsy.”
Emergency mechanical thrombectomy dramatically increases a stroke patient’s chance of a full recovery. The UK does not have enough skilled doctors to provide the procedure. NHS England plans to roll out the technique nationally, but will need at least another 50 extra specially trained radiologists.
Teleflex has announced the completion of its previously announced acquisition of NeoTract.
Global specialist healthcare company BTG has highlighted the commencement of the KNOCOUT PE study. The KNOCOUT PE study will measure how hospitals and patients are benefitting from a new standard of care in the treatment of pulmonary embolism utilising the company’s EKOS therapy with faster and safer protocols, following the encouraging results of the OPTALYSE PE study.
Venous stenting has evolved over the last 15 years, quickly becoming an established procedure, with Class II recommendations from the American Heart Association and American College of Phlebology. Speaking at the Vascular Society of Great Britain and Ireland’s Annual Scientific Meeting (VSGBI; 22–24 November 2017, Manchester, UK), Ankur Thapar presented results from the Venous Research Unit at Imperial College (London, UK) reviewing an expert consensus on antithrombotic therapy following venous stenting.
Global healthcare company Penumbra has entered into a joint venture with virtual reality (VR) company Sixense Enterprises, for the purpose of exploring healthcare applications of the technology.
Endovascular navigation startup Centerline Biomedical has successfully completed a fifth preclinical study at Cleveland Clinic facilities evaluating its surgical navigation system, the Intra-Operative Positioning System (IOPS). The study was the company’s most noteworthy study to date; demonstrating ability to track sensorised IOPS instruments precisely and efficiently with enhanced three-dimensional (3D) visualisation and without frequent exposure to cancer-causing ionising radiation associated with current standard of care.
The first patients have been enrolled in the US FDA pivotal study of VasQ (Laminate Medical Technologies), an implanted blood vessel external support device for patients requiring arteriovenous fistula as vascular access for haemodialysis.
Bluegrass Vascular Technologies has announced the enrolment of its first patients in the SAVE-US (Surfacer System to Facilitate Access in Venous Occlusions–United States) pivotal trial.
Dosimetry, within the context of selective internal radiation therapy (SIRT) using Y-90 microspheres, is typically understood to be the measurement and calculation of the absorbed dose in matter and tissue resulting from the exposure to indirect and direct ionising radiation.